Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung Transplant in Tandem With Bone Marrow Transplant
NCT03500731Phase 2Recruiting
- Sponsor
- Paul Szabolcs
- Start
- Apr 2018
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of hematopoietic stem cells in idiopathic pulmonary fibrosis (IPF), emphysema, chronic obstructive pulmonary disease (COPD), bone marrow failure, sponsored by Paul Szabolcs. Started Apr 2018; status: recruiting.
02
Drugs
hematopoietic stem cells
03
Conditions
idiopathic pulmonary fibrosis (IPF)emphysemachronic obstructive pulmonary disease (COPD)bone marrow failure
Beyond the preview
Go deeper on NCT03500731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03500731.